At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 enrolled
Drug / intervention
Chlorhexidine Gluconate 2% Wipe +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
In Brief
A Phase 2 clinical trial evaluating Chlorhexidine Gluconate 2% Wipe and Placebo Wipe for Stem Cell Transplant Complications. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study evaluates the use of 2% CHG washcloths in an outpatient setting for adults after hematopoietic stem cell transplant in prevention of central line associated blood stream infections. Half of the participants will use 2% CHG washcloths and other half will use placebo washcloths.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStem Cell Transplant Complications
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJan 2017
First PostedJan 2017
Primary CompletionJan 2019
Study CompletionJun 2019
TodayJul 2026
First PostedJan 25, 2017
Enrollment StartJan 1, 2017
Primary CompletionJan 2, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.4 years ago
Interventions
Chlorhexidine Gluconate 2% Wipedrug
Placebo Wipedrug